Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Evnin Luke
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   330,044    

Indirect Shares

  35,767,143      
Direct Value   $449,921    

Indirect Value

  $120,833,870      
Total Shares   36,097,187      
Total Value   $121,283,791      


iPass Inc
 $0 Tcr2 Therapeutics Inc.
 $449,921 iPass Inc
 $0 Tcr2 Therapeutics Inc.
 $449,921
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Oscient Pharmaceuticals Corp OSCIQ Director 0 2006-01-05 2,272,935    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Rigel Pharmaceuticals Inc RIGL 10% Owner 2004-07-02 0 2004-07-02 1,833,597    Premium*  
            iPass Inc IPAS 10% Owner 2004-02-09 26,043 2004-02-09 262,533    Premium*  
            Hemosense Inc HEM 10% Owner 2005-07-01 0 2007-11-06 0    Premium*  
            American Cryostem Corporation CRYO 10% Owner 2005-07-13 0 2005-07-19 2,931,531    Premium*  
            Radius Health Inc. RDUS Former 10% stockholder 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Director 2013-06-13 0 2013-06-13 824,255    Premium*  
            Syndax Pharmaceuticals Inc SNDX Director, 10% Owner 2016-03-08 0 2016-03-08 2,168,691    Premium*  
            Harpoon Therapeutics, Inc. HARP Former 10% Owner 2019-02-12 0 2021-04-15 3,220,844    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2020-06-23 3,003,772    Premium*  
            Oncorus, Inc. ONCR Director, 10% Owner 0 2020-10-06 2,492,843    Premium*  
            Turmeric Acquisition Corp. TMPM Chief Executive Officer 2020-10-20 0 2020-10-20 415,500    Premium*  
            Werewolf Therapeutics, Inc. HOWL Director, 10% Owner 0 2021-05-04 4,284,172    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-22 304,001 2023-05-22 3,370,977    Premium*  
* Premium Members only  

Records found :    107         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
HEM Hemosense Inc 10% Owner   –       –       •   2007-11-06 4 D $0.00 $0 I/I (3,828,319) 0 0 -
RDUS Radius Health Inc. 10% Owner   –       –       •   2011-05-17 4 D $0.01 $50,000 I/I (5,000,000) 0 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-06-13 4 AS $30.07 $610,843 D/D (20,311) 0 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-06-12 4 AS $30.00 $73,050 D/D (2,435) 20,311 0 -
IPAS iPass Inc 10% Owner   –       –       •   2004-02-09 4 A $0.00 $0 D/D 26,043 26,043 -
PCRX Pacira Pharmaceuticals, I... Director   –       •       •   2011-02-02 3 IO $0.00 $0 I/I 0 92,980 -
ONCR Oncorus, Inc. Director   –       •       •   2020-10-01 3 IO $0.00 $0 I/I 0 115,823 -
CRYO American Cryostem Corpora... 10% Owner   –       –       •   2005-07-13 4 B $11.00 $1,980,000 I/I 180,000 180,000 1.5 -
IPAS iPass Inc 10% Owner   –       –       •   2004-02-09 4 D $0.00 $0 I/I (1,986,385) 262,533 -
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-22 4 S $1.88 $131,920 D/D (70,170) 304,001 0 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-22 4 OE $0.74 $131,919 D/D 178,269 374,171 0 -
TMPM Turmeric Acquisition Corp... Chief Executive Officer   •       –      –    2020-10-20 4 A $10.00 $4,155,000 I/I 415,500 415,500 0 -
HOWL Werewolf Therapeutics, In... Director   –       •       •   2021-04-29 3 IO $0.00 $0 I/I 0 461,408 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-06-03 4 AS $30.00 $2,462,160 I/I (82,072) 824,255 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-31 4 AS $30.00 $298,050 I/I (9,935) 906,327 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-30 4 AS $30.00 $1,337,460 I/I (44,582) 916,262 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-29 4 AS $30.00 $612,330 I/I (20,411) 960,844 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-28 4 AS $30.62 $6,039,523 I/I (195,117) 981,255 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-24 4 AS $30.04 $189,342 I/I (6,303) 1,163,486 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-23 4 AS $30.00 $3,243,450 I/I (108,115) 1,169,789 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-22 4 AS $30.00 $220,200 I/I (7,340) 1,176,372 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-05-20 4 AS $30.00 $406,500 I/I (13,550) 1,183,712 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-15 4 AS $30.00 $77,250 I/I (2,575) 1,277,904 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-12 4 AS $30.00 $300,000 I/I (10,000) 1,280,479 0 -
PCRX Pacira Pharmaceuticals, I... Director   –       •      –    2013-04-12 4 S $29.30 $100,089 I/I (3,416) 1,314,255 0 -

  107  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed